Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Observer.
Press releases published on June 26, 2025

Crown of Life and Financial Harvest Announce First NFL Player Affiliation
WINTER PARK, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- Crown of Life Advisors proudly announces its affiliation with NFL wide receiver Jaylin Lane. Crown of Life is a division of Financial Harvest Wealth Advisors, dedicated to providing personalized wealth …

Rising Demand for Drones for Commercial & Military Applications Becoming a Booming Revenue Opportunity
PALM BEACH, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Unmanned Aerial Vehicle (UAV) imagery service providers have been offering innovative opportunities for businesses in the construction …

Alliance Entertainment Secures Exclusive North American Distribution for Master Replicas Collectibles
PLANTATION, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: AENT) (“Alliance” or the “Company”), a premier global distributor and fulfillment partner of entertainment and pop culture collectibles, today announced …

Increasing Adoption of Drones in Commercial Sectors Leading to a Revolution in Big Data Cloud Services
PALM BEACH, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The increasing adoption of drones in commercial sectors is leading to a revolution in big data cloud services. Launching a drone to capture images is the preliminary step …

Upexi Announces Intent to List SEC-Registered Shares On-Chain via Superstate’s Opening Bell
TAMPA, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space, …

HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements
MIRAMAR, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan by …

ZyVersa Therapeutics Announces First Clinical Site Activation, Initiating Patient Recruitment for Cholesterol Efflux Mediator™ VAR 200’s Phase 2a Clinical Trial in Patients with Diabetic Kidney Disease (DKD)
Initiation of patient recruitment marks a key milestone in the development of VAR 200, a potential first-in-class treatment for kidney disease addressing renal lipotoxicity. There are no available drugs targeting renal lipotoxicity that damages the kidneys …